Crossref
The use of 5 alpha-reductase in the era of minimally invasive surgical therapies (MISTs): Is it still valuable?
Uro-Technology Journal · 2024
DOI: 10.31491/utj.2024.09.022 ↗Kurz gefasst
Fachartikel in der Zeitschrift Uro-Technology Journal, 2024. Verfasst von Francesco Greco und 1 weiteren Autor:innen.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Zitieren
APA
Greco, F., & omanico, L. D. (2024). The use of 5 alpha-reductase in the era of minimally invasive surgical therapies (MISTs): Is it still valuable?. Uro-Technology Journal. https://doi.org/10.31491/utj.2024.09.022
Vancouver
Greco F, omanico LD. The use of 5 alpha-reductase in the era of minimally invasive surgical therapies (MISTs): Is it still valuable?. Uro-Technology Journal. 2024. doi:10.31491/utj.2024.09.022
BibTeX
@article{Greco2024,
author = {Greco, Francesco and omanico, Luigi D},
title = {The use of 5 alpha-reductase in the era of minimally invasive surgical therapies (MISTs): Is it still valuable?},
journal = {Uro-Technology Journal},
year = {2024},
doi = {10.31491/utj.2024.09.022}
}
EUVIMED